Man

Ramon Luis Corbalan Herreros

Director

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

SANTIAGO, Chile

Líneas de Investigación


Signal Transduction; Cardiovascular Pathology; Metabolic Disorders: Diabetes; Cell Death: Apoptosis, Autophagia, Necrosis; Cardiovascular Disorders; Atrial Fibrilation; ischemic heart disease; Heart Failure

Educación

  •  Medical Doctor, PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE. Chile, 1966

Experiencia Académica

  •   Professor of Medicine Full Time

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    Medicine

    Santiago, Chile

    1966 - A la fecha

Experiencia Profesional

  •   Bachelor in Biology Other

    Universidad de Chile

    Chile

    1968 - 1968

  •   Research Fellow in Cardiology Full Time

    Universidad de Harvard

    Estados Unidos

    1972 - 1974

Formación de Capital Humano


1997: Tutor de Semiología para el Curso Integrado de Clínicas Médico-Quirúrgica MEC 231, alumnos de tercer año de Medicina. 60 horas docentes
1997: Tutor en Seminarios de Cardiología para alumnos de tercer y Cuarto Año de Medicina. 6 horas docentes
1998: Tutor de Semiología para el Curso Integrado de Clínicas Médico-Quirúrgica MEC 231, alumnos de tercer año de Medicina. 60 horas docentes
1998-2002: Tutor de Semiología para el Curso Integrado de Clínicas Médico-Quirúrgica MEC 231, alumnos de tercer año de Medicina. 60 horas docentes
1997-1999: Docente tutor internos de Medicina durante rotación en Unidad Coronaria. 500 horas docentes anuales
2002: Tutor de Semiología para el Curso Integrado de Clínicas Médico-Quirúrgica MEC 231, alumnos de tercer año de Medicina. 60 horas docentes
2002: Core Curriculum, Prevención Primaria y Secundaria para becados de Cardiología
2003: Tutor de Semiología para el Curso Integrado de Clínicas Médico-Quirúrgica MEC 231, alumnos de tercer año de Medicina. 60 horas docentes
2003: Tutor en Seminarios de Cardiología para alumnos de tercer Año de Medicina. 9 horas docentes
2003- a la fecha Core curriculum becados de Cardiologia


Premios y Distinciones

  •   Premio Trayectoria Académica

    PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

    Chile, 2011

    Premio otorgado por la Facultad de Medicina de la Pontificia Universidad Católica de Chile.

  •   Mejor Trabajo

    SOCIEDAD MEDICA DE SANTIAGO

    Chile, 2003

    Premio a trabajo Reducción de la Mortalidad por Infarto del Miocardio en Hospitales Chilenos

  •   Mejor Trabajo

    SOCIEDAD CHILENA DE CARDIOLOGIA Y CIRUGIA CARDIOVASCULAR

    Chile, 1992

    Mejor trabajo, otorgado en Congreso de la Sociedad Chilena de Cardiologia

  •   Fundación Mac Clure

    SOCIEDAD CHILENA DE CARDIOLOGIA Y CIRUGIA CARDIOVASCULAR

    Chile, 1986

    The best clinical paper presented at the XXIII National Congress of the Chilean Society of Cardiology and Cardiovascular Surgery. Efectos Clínicos de Infusiones de Dobutamina y Amrinona en Pacientes con Insuficiencia Cardiaca Refractaria.

  •   Premio "Dr. Corbalan Melgarejo 2000

    SOCIEDAD MEDICA DE SANTIAGO

    Chile, 1999

    The best clinical paper "Infarto agudo al Miocardio en Hospitales Chilenos. Resultados Finales del estudio GEMI".


 

Article (111)

Cardiovascular clinical research in South America
Carotid intima media thickness and C reactive protein among overweight or obese subjects without metabolic syndrome
Cholesterol Levels and the Association of Statins With In-Hospital Mortality of Myocardial Infarction Patients Insights From a Chilean Registry of Myocardial Infarction
Global Variation in Quality of Care Among Patients Hospitalized With Acute Heart Failure in an International Trial Findings From the Acute Study Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF)
¿Sirven los marcadores de riesgo no tradicionales en la diferenciación del riesgo cardiovascular en adultos jóvenes con exceso de peso?
Assessment of Left Atrial Function in Hypertrophic Cardiomyopathy and Athlete's Heart: A Left Atrial Myocardial Deformation Study
Atherothrombotic Disease, Traditional Risk Factors, and 4-Year Mortality in a Latin American Population: The REACH Registry
Biochemical predictors of cardiac rhythm at 1 year follow-up in patients with non-valvular atrial fibrillation
Biochemical predictors of cardiac rhythm at 1 year follow-up in patients with non-valvular atrial fibrillation
Global Variation in the Prevalence of Elevated Cholesterol in Outpatients With Established Vascular Disease or 3 Cardiovascular Risk Factors According to National Indices of Economic Development and Health System Performance
Impaired cardiac autophagy in patients developing postoperative atrial fibrillation
Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization
Relación colesterol total a HDL y colesterol no HDL: los mejores indicadores lipídicos de aumento de grosor de la íntima media carotidea
Asociación entre strain y strain rate auricular izquierdo evaluado por speckle tracking y fibrilación auricular post cirugía de revascularización miocárdica
Cardiovascular risk factors among young subjects with high carotid intima media thickness
Chilean results of the international registry of risk factors and treatment of unstable angina and non ST elevation myocardial infarction: ACCORD (ACute CORonary syndrome Descriptive study)
Effect of Nesiritide in Patients with Acute Decompensated Heart Failure
Geographic Variation in Clinical Course Among Patients Hospitalized for Acute Heart Failure: Insights From ASCEND-HF
Left Atrial Dysfunction Is a Predictor of Postcoronary Artery Bypass Atrial Fibrillation: Association of Left Atrial Strain and Strain Rate Assessed by Speckle Tracking
Perfil de riesgo cardiovascular en adultos jóvenes asintomáticos con grosor íntima media carotídeo elevado
Resultados Chilenos del registro internacional de factores de riesgo y tratamiento de angina inestable e infarto al miocardio sin supradesnivel del segmento ST: ACCORD (ACute CORonary syndrome Descriptive study)
Systemic vascular cell adhesion molecule-1 predicts the occurrence of post-operative atrial fibrillation
Admission hyperglycemia and mortality of ST segment elevation myocardial infarction
Admission hyperglycemia and mortality of st segment elevation myocardial infarction Implicancias de la glicemia de ingreso en la mortalidad intrahospitalaria y alejada según el método de reperfusión en pacientes con infarto agudo del miocardio y supradesnivel del segmento ST
Attained Educational Level and Incident Atherothrombotic Events in Low- and Middle-Income Compared With High-Income Countries
Depressive symptoms among patients with acute myocardial infarction. Relationship with revascularization therapy
Depressive symptoms among patients with acute myocardial infarction. Relationship with revascularization therapy Prevalencia y evolución de síntomas depresivos en pacientes hospitalizados por infarto agudo al miocardio y su relación con procedimientos de revascularización
Implicancias de la glicemia de ingreso en la mortalidad intrahospitalaria y alejada según el método de reperfusión en pacientes con infarto agudo del miocardio y supradesnivel del segmento ST
Long term follow up of patients consulting in a Chest Pain Unit
Long term follow up of patients consulting in a chest pain unit Seguimiento alejado de pacientes evaluados en una unidad de dolor torácico
Prevalencia y evolución de síntomas depresivos en pacientes hospitalizados por infarto agudo al miocardio y su relación con procedimientos de revascularización
Seguimiento alejado de pacientes evaluados en una Unidad de Dolor Torácico
Actividad física y potencia aeróbica: ¿Cómo influyen sobre los factores de riesgo cardiovascular clásicos y emergentes?
Association between cardiorespiratory fitness and cardiovascular risk factors in healthy individuals
Association between cardiorespiratory fitness and cardiovascular risk factors in healthy individuals Actividad física y potencia aeróbica: ¿Cómo influyen sobre los factores de riesgo cardiovascular clásicos y emergentes?
Cardiac dyssynchrony correlates with left ventricular remodeling after myocardial infarction
Cardiac dyssynchrony correlates with left ventricular remodeling after myocardial infarction La disincronía cardíaca se correlaciona con el remodelado ventricular izquierdo postinfarto agudo al miocardio
Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials
La disincronía cardíaca se correlaciona con el remodelado ventrícular izquierdo postinfarto agudo al miocardio
Modificación del grosor intima-media carotídeo según factores de riesgo clásicos y síndrome metabólico con o sin inflamación
Response to Letter Regarding Article, Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial I
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38
History of hypertension and eplerenone in patients with acute myocardial infarction complicated by heart failure
Impacto de la trombolisis y de la angioplastia primaria en pacientes con infarto agudo del miocardio tratados en centros hospitalarios terciarios
In-hospital mortality after ST-segment elevation myocardial infarction according to reperfusion therapy
In-hospital mortality after ST-segment elevation myocardial infarction according to reperfusion therapy Mortalidad intrahospitalaria en hombres y mujeres según terapias de reperfusión en infarto agudo del miocardio con supradesnivel del ST
Mortalidad intrahospitalaria en hombres y mujeres según terapias de reperfusión en infarto agudo del miocardio con supradesnivel del ST
Mortality of patients with ST-elevation acute myocardial infarction treated with primary angioplasty or thrombolysis
Mortality of patients with ST-elevation acute myocardial infarction treated with primary angioplasty or thrombolysis Impacto de la trombolisisy de la angioplastia primaria en pacientes con infarto agudo del miocardio tratados en centros hospitalarios terciarios
Predictores de síndrome coronario agudo sin supradesnivel del ST y estratificación de riesgo en la unidad de dolor torácico. Experiencia en 1.168 pacientes
Predictors of acute coronary syndrome without ST segment elevation and risk stratification in the chest pain unit Predictores de síndrome coronario agudo sin supradesnivel del ST y estratificación de riesgo en la unidad de dolor torácico. Experiencia en 1.168 pacientes
Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis
The impact of Chilean health reform in the management and mortality of ST elevation myocardial infarction (STEMI) in Chilean hospitals
Chest pain unit: first experience in Chile
Chest pain unit: First experience in Chile Unidad de dolor torácico: Primera experiencia en Chile
Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis
Risk factors for postoperative atrial fibrillation after coronary artery bypass grafting. A prospective analysis
Unidad de dolor torácico: primera experiencia en Chile
C-reactive protein and atrial fibrillation: Evidence for the presence of inflammation in the perpetuation of the arrhythmia"
Enoxaparin is superior to unfractionated heparin in patients with STEMI undergoing fibrinolysis regardless of the choice of lytic-type: ExTRACT-TIMI 25 analysis
Evaluation of eplerenone in the subgroup of EPHESUS patients with baseline left ventricular ejection fraction <= 30%
Evaluation of eplerenone in the subgroup of EPHESUS patients with baseline left ventricular ejection fraction ?30% Beurteilung der wirkung von eplerenon in der subgruppe der EPHESUS-patienten mit einer linksventrikulären auswurffraktion ?30% zu studienbeginn
Usefulness of thrombolytic therapy with low doses of streptokinase in acute myocardial infarction
What can we do to modify coronary risk factors? ¿Qué podemos hacer para modificar los factores de riesgo coronario?
Coronary biomarkers and long-term clinical outcome in acute coronary syndrome without ST segment elevation
Effects of carvedilol on oxidative stress and chronotropic response to exercise in patients with chronic heart failure
Effects of Carvedilol upon intra- and interventricular synchrony in patients with chronic heart failure
Efficacy of zoniporide, an Na/H exchange ion inhibitor, for reducing perioperative cardiovascular events in vascular surgery patients
Prevalence of cardiovascular risk factors among patients suffering vascular events on admission and one year later
Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes
Effects of carvedilol on functional capacity, left ventricular function, catecholamines and oxidative stress in patients with chronic heart failure
Effects of carvedilol on functional capacity, left ventricular function, catecholamines and oxidative stress in patients with chronic heart failure Efectos del carvedilol en la capacidad funcional, función ventricular izquierda, catecolaminas y estrés oxidativo en pacientes con insuficiencia cardíaca crónica
Prognostic value of hyperuricemia in chronic heart failure
Administration of growth hormone to patients with advanced cardiac heart failure: effects upon left ventricular function, exercise capacity, and neurohormonal status
Changes in drug prescription and reduction of hospital mortality in patients with acute myocardial infarction Cambios e la prescripción de medicamentos y reduccion de la mortalidad intrahospitalaria en pacientes con infarto agudo del miocardio
Effects of glucose-insulin-potassium solution on myocardial salvage and left ventricular function after primary angioplasty
From multicenter trial to national registries: The truth about the management of myocardial infarction De los estudios multicéntricos a los registros nacionales: La verdad sobre el tratamiento del infarto de miocardio
Long-term automated peritoneal dialysis in patients with refractory congestive heart failure.
PREDICTORES ECOCARDIOGRAFICOS DE RITMO SINUSAL A 30 DIAS Y 1 AÑO EN PACIENTES CON FIBRILACION AURICULAR NO VALVULAR
PROTEINA C REACTIVA Y FIBRILACION AURICULAR: EVIDENCIA DE UN PROCESO INFLAMATORIO EN LA INICIACION Y PERPETUACION DE LA ARRITMIA
Relation between oxidative stress, catecholamines, and impaired chronotropic response to exercise in patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
A 36 years experience with implantable pacemakers
Coronary artery surgery in the first 24 hours after myocardial infarction
Effects of early decrease in oxidative stress after medical therapy in patients with class IV congestive heart failure
Hypercoagulability in atrial fibrillation and its relationship with risk factors for systemic embolism Hipercoagulabilidad en fibrilación auricular y su relación con factores de riesgo para embolia sistémica.
Oxidative stress after reperfusion with primary coronary angioplasty: Lack of effect of glucose-insulin-potassium infusion
Persistence of oxidative stress after heart tranplantation: A comparative study of patients with heart transplant versus chronic stable heart failure
Persistence of oxidative stress after heart transplantation: A comparative study of patients with heart transplant versus chronic stable heart failure
Reduction of acute myocardial infarction mortality in Chilean hospitals
Association of noninvasive markers of coronary artery reperfusion to assess microvascular obstruction in patients with acute myocardial infarction treated with primary angioplasty
Changes in pharmacotherapy for acute myocardial infarction. Comparison of two periods
Effect of primary coronary angioplasty on left ventricular function and myocardial perfusion as determined by Tc-99m sestamibi scintigraphy
ESTADO DE HIPERCOAGULABILIDAD EN PACIENTES CON FIBRILACION AURICULAR NO VALVULAR Y SU RELACION CON LA FRECUENCIA CARDIACA
Hyperuricemia as a marker for anaerobic threshold in chronic cardiac failure
Issues in early risk stratification for UA/NSTEMI
Selective training of respiratory muscles in patients with chronic heart failure
VARIANTES GENETICAS DE LOS RECEPTORES ADRENERGICOS Y ENFERMEDADES CARDIOVASCULARES
Variation in patient management and outcomes for acute coronary syndromes in Latin America and North America: Results from the Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial
Acute coronary syndrome and advanced age Síndromes coronarios agudos y edad avanzada.
Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation
Chronic hyperventilation syndrome associated with syncope and coronary vasospasm [12]
Infective endocarditis: short and long term results in 261 cases managed by a multidiciplinary approach
The TIMI risk score for unstable angina/non-ST elevation MI - A method for prognostication and therapeutic decision making
Bedside markers of coronary artery patency and short-term prognosis of patients with acute myocardial infarction and thrombolysis
SOLUCION GIK EN EL INFARTO AGUDO AL MIOCARDIO. EL RESURGIMIENTO DE UNA ANTIGUA TERAPIA
Comparison of low molecular weight heparin and unfractionated heparin in the treatment of unstable angina Heparina de bajo peso molecular versus heparina no fraccionada en el tratamiento de la angina inestable
Enalapril restores depressed circulating insulin-like growth factor 1 in patients with chronic heart failure
Selective increase in cardiac IGF-1 in a rat model of ventricular hypertrophy
Cyclic AMP dependent protein kinase and mechanical heart function in ventricular hypertrophy induced by pressure overload or secondary to myocardial infarction
DIFERENTES CARACTERISTICAS EN EL ECOCARDIOGRAMA TRANESOFAGICO DE PACIENTES CON FIBRILACION AURICULAR PAROXISTICA Y CRONICA

Abstract (35)

Differences in treatment and in-hospital mortality of acute myocardial infarction patients in public and private hospitals in Chile before and after healthcare guarantees
One-year outcomes in new versus permanent atrial fibrillation: insights from the prospective, international GARFIELD registry
Twelve-month outcomes in paroxysmal versus permanent atrial fibrillation: data from the prospective, international GARFIELD registry
DOES THE INTIMA MEDIA THICKNESS PREDICT MORTALITY BEYOND TRADITIONAL RISK FACTORS?: SEVEN YEAR FOLLOW UP OF CARMELA-CHILE STUDY
NON TRADITIONAL RISK FACTORS AND MORTALITY: DO THEY ADD INFORMATION BEYOND TRADITIONAL RISK FACTORS?
EXERCISE CAPACITY: THE MOST IMPORTANT DETERMINANT OF MORTALITY IN A HEALTHY MIDDLE AGED POPULATION
Association of left atrial strain and strain rate assessed by speckle tracking with post coronary artery by-pass grafting atrial fibrillation
Evidence of impaired cardiac autophagic flux in patients developing post-operative atrial fibrillation
Changes in Carotid Intima-Media Thickness According to the Presence of the Metabolic Syndrome With and Without Chronic Inflammation
Cholesterol Control in Patients With a History of Hyperlipidemia and Established Vascular Disease Reflects National Economic/Health System Characteristics
CLINICAL AND DEMOGRAPHIC CHARACTERISTICS OF PATIENTS WITH ATRIAL FIBRILLATION IN CHILE
The Impact Of Attained Educational Level On Incident Cardiovascular Events Differs Between High-Income Countries and Low-and-Middle-Income Countries
Achievement of treatment targets of cardiovascular risk factors in a pilot secondary prevention program in Chile
Abdominal obesity, body mass index and physical activity: How do they modify the Framingham risk score?
Abdominal obesity and physical activity: do they add something to the Framingham risk score?
Cardiorrespiratory fitness, metabolic syndrome and subclinical inflammation in a primary prevention cardiology unit
Differences in survival after Myocardial Infarction according to gender: a 5 year follow-up
High blood pressure and diabetes play an important role in the development and prognosis of myocardial infarction in women
Hypertension and hypercholesterolemia: Achievement of treatment targets in a primary prevention population
Trends of cardiovascular risk factors in Chile: prevalence in healthy population and in acute myocardial infarction
White blood cell count increases the prognostic value of the TIMI risk score in acute coronary syndromes
Brain natriuretic peptide levels correlates with functional capacity and pulmonary hemodynamics in patients with primary pulmonary hypertension
Carvedilol corrects interventricular and interventricular dyssynchrony in chronic heart failure.
Impact of gender on cardiovascular risk profile in a healthy population in Chile: Results of the Ricar project
Lack of association of C-reactive protein with subclinical atherosclerosis evaluated by carotid intima-media thickness in a healthy Chilean urban population. A CARMELA substudy
Multiple cardiovascular risk factors among Chilean women according to the presence of myocardial infarction
C-reactive protein and soluble thrombomodulin: biochemical markers of maintenance of sinus rhythm at 1-year follow-up in patients with non-valvular atrial fibrillation
Clinical value of echocardlographic markers for the prediction of sinus rhythm maintenance at 30-day and 1-year follow-up in patients with non-valvular atrial fibrillation
The EPHESUS trial: Effect of eplerenone in patients with a baseline history of hypertension
beta(2)-adrenergic receptor polymorphisms are not associated with heart failure
C-reactive protein and atrial fibrillation: evidence of an inflammatory process in the initiation and perpetuation of the arrhythmia
Thrombin-antithrombin levels are directly associated with heart rate at entry in patients with non-valvular atrial fibrillation
Comparison of oxidative stress status between heart transplant and advanced chronic heart failure patients
Benefits of nocturnal non invasive mechanical ventilation in patients with congestive heart failure with and without sleep apnea
Early decrease in oxidative stress in patients with class IV heart failure after successfull medical therapy

EditorialMaterial (4)

What can we do to modify coronary risk factors?
From multicenter trial to national registries: The truth about the management of myocardial infarction
Has the prognosis of cardiogenic shock post myocardial infarction changed?
Acute coronary syndromes and advanced age

Letter (5)

Response to Letter Regarding Article, "Attained Educational Level and Incident Atherothrombotic Events in Low- and Middle-Income Compared With High-Income Countries"
Matrix metalloproteinase-9 activity is associated to oxidative stress in patients with acute coronary syndrome
Response to Letter Regarding Article, "Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel: Thrombolysis in Myocardial Infarction 38"
Response of letter to the Editor: The impact of inflammation on the development, successful cardioversion, recurrence and/or perpetuation of atrial fibrillation", by Dr Hasan Turhan et al."
Chronic hyperventilation syndrome associated with syncope and coronary vasospasm

Review (1)

Exercise and cardiac rehabilitation in secondary cardiovascular prevention
186
Ramon Corbalan

Director

Division of Cardiovascular Diseases

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

SANTIAGO, Chile

50
MONICA ACEVEDO

Titular Professor

Division of Cardiovascular Diseases

P. UNIVERSIDAD CATOLICA DE CHILE

SANTIAGO, Chile

20
SERGIO LAVANDERO

Director

Advanced Center for Chronic Diseases (ACCDiS)

UNIVERSIDAD DE CHILE, FAC CIENCIAS QUÍMICAS Y FARMACÉUTICAS

Santiago, Chile

15
JORGE JALIL

FULL PROFESSOR

ENFS CARDIOVASCULARES

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE, ESCUELA DE MEDICINA

Santiago, Chile

14
Mario Chiong

Profesor

Departamento de Bioquímica y Biología Molecular

Universidad de Chile

Santiago, Chile

13
Pablo Castro

JEFE DIVISION

DIVISION ENFERMEDADES CARDIOVASCULARES

Pontificia Universidad Católica de Chile

SANTIAGO, Chile

11
Douglas Greig

Médico Jefe

Cardiología

P. Universidad Católica de Chile

Santiago, Chile

11
Carolina Nazzal

Profesor Asociado

Instituto de Salud Poblacional

Universidad de Chile

Santiago, Chile

8
Samuel Cordova

ESCUELA DE MEDICINA, PONTIFICA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

7
Fernando Lanas

Profesor titular

Medicina Interna

UNIVERSIDAD DE LA FRONTERA

Temuco, Chile

6
Hugo Verdejo

Profesor Asociado

División de Enferemedades Cardiovasculares

Pontificia Universidad Católica de Chile

Santiago, Chile

6
Luigi Gabrielli

Profesor Asistente

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Chile

4
Rodrigo Troncoso

Associate Professor

Instituto de Nutrición y Tecnología de los Alimentos

Santiago, Chile

4
Gabriel Cavada

Académico, Jefe de Programa

Instituto de Salud Poblacional

Universidad de Chile

Santiago, Chile

4
Rodrigo Troncoso

Assistant professor

Universidad de Chile, Instituto de Nutrición y Tecnología de los Alimentos

Santiago de Chile, Chile

4
Jaime Pereira

Jefe

Hematología-Oncología

ESCUELA DE MEDICINA, PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

4
Luis Villarroel

Profesor Asociado

Salud Publica

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE, DEPARTAMENTO DE SALUD PÚBLICA

Santiago, Chile

3
Pablo Sepúlveda

Cardiólogo Intervencionista

División de Enfermedades Cardiovasculares

Pontificia Universidad Católica de Chile

Santiago, Chile

3
Juan Carlos Quintana

Médico nuclear

Radiología

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

2
Roberto Ebensperger

Associate Professor

Pharmacy

Pontificia Universidad Católica de Chile

Santiago, Chile

2
Rosemarie Mellado

Jefe de carrera / Académica

Farmacia

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

2
Lorena Garcia

Assistant Professor

Bioquimica y Biologia Molecular

UNIVERSIDAD DE CHILE

Santiago, Chile

2
Paola Viviani

Profesor Asistente, categoría Ordinaria

Salud Pública

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

SANTIAGO, Chile

2
Pedro Pérez

Profesor Asociado

Medicina Interna

Pontificia Universidad Católica de Chile

Santiago, Chile

1
Alex Escalona

Assistant Professor

Cirugía Digestiva

Pontificia Universidad Catolica de Chile

Santiago, Chile

1
Sergio González

FACULTAD DE MEDICINA. PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

1
Attilio Rigotti

Full Professor

Nutrition, Diabetes and Metabolism

Pontificia Universidad Católica de Chile

Santiago, Chile

1
Juan Prieto

Profesor Titular

Programa de Farmacología Molecular y Clínica

Universidad de Chile

Santiago, Chile

1
Attilio Rigotti

Full Professor

Nutrition, Diabetes and Metabolism

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE - ESCUELA DE MEDICINA - DEPTO DE GASTROENTEROLOGÍA

Santiago, Chile

1
Andrea del Campo

Profesor Asistente, Investigador Principal

Departamento de Farmacia

Pontificia Universidad Católica de Chile

Santiago, Chile

1
Juan Ossa

Profesor asistente

Pediatria y Cirugia Oriente

Universidad De Chile, Hospital Luis Calvo Mackenna

Santiago, Chile

1
Mario Fernandez

Associate Professor

Urology

CLÍNICA ALEMANA DE SANTIAGO

Santiago, Chile

1
Orlando Diaz

Profesor Asociado

Enfermedades Respiratorias

PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE

Santiago, Chile

1
Rodrigo Valenzuela

Postdoctorado

Oftalmología

Universidad de Chile

Santiago, Chile

1
Gonzalo Martínez

Director

División de Enfermedades Cardiovasculares

Hospital Clínico Universidad Católica

Santiago, Chile

1
Daniel Morales

Jefe Unidad Paciente Critico

Unidad de Paciente Critico (UPC)

Hospital La Florida

Santiago, Chile

1
Jovan Kuzmicic

Profesor Asistente

Departamento Salud

Universidad de Los Lagos

Osorno, Chile